Phase III Study of KX-826 With Adult Male Patients With AGA

NCT06126965 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

740

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia

Interventions

DRUG: KX-826-（5%） BID
OTHER: Placebo

Sponsor

Suzhou Kintor Pharmaceutical Inc,

Collaborators

[object Object]